Fiona Kaper's 10 research works with 2,404 citations and 626 reads, including: Connective Tissue Growth Factor–Specific Monoclonal Antibody Therapy Inhibits Pancreatic Tumor...

2015年6月3日 · Of clinical significance, we propose that mtDNA content represents a novel biomarker with potential value for in vitro fertilisation (IVF) treatment, revealing chromosomally normal blastocysts incapable of producing a viable pregnancy. Mitochondria are small membrane-enclosed structures and are found inside the cells of the body.

Fiona Kaper's 24 research works with 2,465 citations and 4,925 reads, including: Circulating transcripts in maternal blood reflect a molecular signature of early-onset preeclampsia

2020年9月10日 · Fiona Kaper, PhD, Illumina’s senior director of Scientific Research, and senior author on the paper, kicked off the C-RNA research program six years ago. She believed these molecules might reveal key information about placenta, mother and infant, delivering biomarkers that could identify pregnancy complications.

Fiona Kaper. Staff Writers Adrian Cho Christie Wilcox Daniel Clery David Grimm David Malakoff Dennis Normile Elizabeth Culotta Elizabeth Pennisi Eric Hand Erik Stokstad Jeffrey Brainard Jeffrey Mervis Jennifer Couzin-Frankel Jocelyn Kaiser John Travis Jon …

2016年1月18日 · We developed pathway and gene set overdispersion analysis (PAGODA) to resolve multiple, potentially overlapping aspects of transcriptional heterogeneity by testing gene sets for coordinated...

2019年10月1日 · Fiona Kaper Illumina, Inc: San Diego, CA, US 2015-04 to 2016-11 | Associate Director (Reproductive and Genetic Health)

selected publications . academic article. Highly parallel genome-wide expression analysis of single mammalian cells..PloS one.7:-. 2012

Fiona Kaper has an extensive professional history, having held various key positions at Illumina. Currently, she serves as the Vice President and Distinguished Scientist at Illumina, showcasing her expertise and leadership in the field.